It is hard to imagine that a leader so capable of paying "market rates" to himself is unable to work out a way of making money.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025